XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stockholders' Equity
12 Months Ended
Dec. 29, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

Note 8: Stockholders’ Equity

Preferred Stock

The Company has authorized 2,000,000 shares of undesignated preferred stock with a par value of $0.001 per share. None of the preferred shares were issued and outstanding at December 29, 2023 and December 30, 2022.

Dividends

The Company declared and paid cash dividends per share of common stock during the periods presented as follows:

 

 

Fiscal Years

 

 

 

2023

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.260

 

 

$

13,169

 

Second Quarter

 

$

0.260

 

 

 

13,217

 

Third Quarter

 

$

0.260

 

 

 

13,177

 

Fourth Quarter

 

$

0.260

 

 

 

13,148

 

 

 

 

 

$

52,711

 

 

 

 

 

 

 

 

 

 

Fiscal Years

 

 

 

2022

 

 

 

Dividends

 

 

Amount

 

 

 

Per Share

 

 

(in thousands)

 

First Quarter

 

$

0.240

 

 

$

12,383

 

Second Quarter

 

$

0.240

 

 

 

12,345

 

Third Quarter

 

$

0.240

 

 

 

12,225

 

Fourth Quarter

 

$

0.240

 

 

 

12,153

 

 

 

 

 

$

49,106

 

Treasury Stock

Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $1,009,000, $1,392,000 and $1,679,000 were recorded as a reduction to retained earnings during 2023, 2022 and 2021, respectively.

Repurchase of Common Stock

The Company repurchased 288,000 shares of its common stock for $24,208,000 during 2023. The Company repurchased 1,756,000 shares of its common stock for $155,856,000 during 2022. The Company repurchased 78,000 shares of its common stock for $7,000,000 during 2021. On February 22, 2022, the Board of Directors authorized $150,000,000 for the repurchase of the Company’s common stock. On May 29, 2020, the Board of Directors authorized $45,000,000 for the repurchase of the Company’s common stock. These repurchase programs have no expiration dates. As of December 29, 2023, the Company had remaining authorization under its stock repurchase plan of $38,390,000 to repurchase shares of common stock.